We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, James G. Greene is the likely recipient of the following grants.
| Years |
Recipients |
Code |
Title / Keywords |
Matching
score |
| 1993 — 1997 |
Greene, James G |
F30Activity Code Description:
Individual fellowships for predoctoral training which leads to the combined M.D./Ph.D. degrees. |
Neurobiology and Anatomy @ University of Rochester |
0.966 |
| 2005 — 2009 |
Greene, James G |
K08Activity Code Description:
To provide the opportunity for promising medical scientists with demonstrated aptitude to develop into independent investigators, or for faculty members to pursue research aspects of categorical areas applicable to the awarding unit, and aid in filling the academic faculty gap in these shortage areas within health profession's institutions of the country. |
Molecular Mechanism of Selective Neuronal Vulnerability
DESCRIPTION (provided by applicant): Like most neurodegenerative disorders, Parkinson's disease (PD) has as its pathological hallmark specific degeneration of certain neuronal subtypes. Specifically, dopamine neurons in the substantia nigra (SN) are exquisitely sensitive to damage in human PD and in animal models of PD, such as administration of the mitochondrial complex I poison rotenone (a common pesticide) to rats. This is in contrast to the relative resistance of other types of neurons. The molecular underpinnings for this selective neuronal vulnerability are unknown. Since inhibition of mitochondrial metabolism by rotenone recapitulates behavioral signs and neuropathological findings of PD, we hypothesize that differences in energy metabolism between susceptible and resistant neurons might underlie differential vulnerability. In the current proposal, we will: (1) evaluate the metabolic transcriptional response to complex I inhibition; (2) test the acute regulation of energy metabolism in dopamine neurons; and (3) determine if modulation of energy metabolism is protective in an in vitro model of PD. These experiments will provide a detailed understanding of mitochondrial energy metabolism in dopamine neurons and give insight into the pathogenesis and potential treatment of PD. The research outlined above is part of a customized five-year plan of training and career development for the Principal Investigator. The proposal includes active mentoring by experienced scientists, access to diverse resources, and an environment uniquely suited to help the PI develop as an independent physician scientist.
|
1 |